AbbVie Inc. (ABBV) Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA®)

AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA®) for…

Canopy Growth Corporation (CGC) Announces Refinancing of C$100 million of Notes due 2023

Canopy Growth Announces Refinancing of C$100 million of Notes due 2023 Canopy…

TerrAscend Corp. (TRSSF) Executive Chairman to Give Keynote at Benzinga Cannabis Capital Conference

TerrAscend Executive Chairman to Give Keynote at Benzinga Cannabis Capital Conference TerrAscend…